Etiology and clinical study of community-acquired pneumonia in 157 hospitalized children. 2006

Takeshi Tajima, and Eiichi Nakayama, and Yasuo Kondo, and Fumie Hirai, and Hiroaki Ito, and Taketoshi Iitsuka, and Mei Momomura, and Hirokazu Kutsuma, and Yuri Kodaka, and Naomi Funaki, and Yukishige Yanagawa, and Kimiko Ubukata
Department of Pediatrics, Hakujikai Memorial Hospital, 5-11-1 Shikahama Adachi-ku, Tokyo 123-0864, Japan. tajima@hakujikai.or.jp

We tried to verify whether the currently employed diagnosis and treatment of community-acquired pneumonia in children were appropriate. For this purpose, we created tentative criteria for the classification of pediatric community-acquired pneumonia. We classified the community-acquired pneumonia into ten categories: (1) bacterial, (2) concomitant viral-bacterial, (3) viral, (4) mycoplasmal, (5) concomitant mycoplasmal-bacterial, (6) concomitant mycoplasmal-viral, (7) chlamydial, (8) concomitant chlamydial-bacterial, (9) concomitant chlamydial-viral, and (10) unknown. Children aged 1 month to 13 years with radiographic and clinical evidence of pneumonia were enrolled. Between October 2001 and September 2002, we enrolled 165 patients. The etiologic agents were determined in 126 of the 157 (80.3%) patients who were finally diagnosed with pneumonia. Two blood cultures were positive for Haemophilus influenzae type b and Streptococcus pneumoniae. A viral infection alone was found in 28 of the 157 patients (17.8%), a bacterial (without mycoplasmal) alone infection in 42 (26.8%), a concomitant viral-bacterial infection in 28 (17.8%), and a mycoplasmal infection in 27 (17.2%) patients. RS virus was identified in 28 patients (17.8%), influenza A in 12 (7.6%), parainfluenza 3 in 8 (5.1%), adenovirus in 8 (5.1%), and influenza B and measles virus in 1 patient each. Streptococcus pneumoniae was the most common cause of bacterial pneumonia. We chose the initial treatment according to clinical and laboratory findings on admission (i.e., patients' age, clinical course, chest X-ray, and laboratory findings). In 68 of the 71 patients with bacterial (without mycoplasmal) pneumonia, an appropriate antibacterial-agent was prescribed. In 25 of the 27 patients with mycoplasmal pneumonia, clindamycin and minocycline were prescribed.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D009175 Mycoplasma Infections Infections with species of the genus MYCOPLASMA. Eperythrozoonosis,Infections, Mycoplasma,Eperythrozoonoses,Infection, Mycoplasma,Mycoplasma Infection
D010343 Patient Admission The process of accepting patients. The concept includes patients accepted for medical and nursing care in a hospital or other health care institution. Voluntary Admission,Admission, Patient,Admission, Voluntary,Admissions, Patient,Admissions, Voluntary,Patient Admissions,Voluntary Admissions
D010818 Practice Patterns, Physicians' Patterns of practice related to diagnosis and treatment as especially influenced by cost of the service requested and provided. Clinical Practice Patterns,Physician's Practice Patterns,Clinical Practice Pattern,Pattern, Clinical Practice,Patterns, Clinical Practice,Practice Pattern, Clinical,Practice Patterns, Clinical,Practice Patterns, Physician's,Prescribing Patterns, Physician,Physician Practice Patterns,Physician Prescribing Pattern,Physician Prescribing Patterns,Physician's Practice Pattern,Physicians' Practice Pattern,Physicians' Practice Patterns,Practice Pattern, Physician's,Practice Pattern, Physicians',Practice Patterns, Physician,Prescribing Pattern, Physician
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children

Related Publications

Takeshi Tajima, and Eiichi Nakayama, and Yasuo Kondo, and Fumie Hirai, and Hiroaki Ito, and Taketoshi Iitsuka, and Mei Momomura, and Hirokazu Kutsuma, and Yuri Kodaka, and Naomi Funaki, and Yukishige Yanagawa, and Kimiko Ubukata
April 2000, The Pediatric infectious disease journal,
Takeshi Tajima, and Eiichi Nakayama, and Yasuo Kondo, and Fumie Hirai, and Hiroaki Ito, and Taketoshi Iitsuka, and Mei Momomura, and Hirokazu Kutsuma, and Yuri Kodaka, and Naomi Funaki, and Yukishige Yanagawa, and Kimiko Ubukata
March 2018, Journal of medical virology,
Takeshi Tajima, and Eiichi Nakayama, and Yasuo Kondo, and Fumie Hirai, and Hiroaki Ito, and Taketoshi Iitsuka, and Mei Momomura, and Hirokazu Kutsuma, and Yuri Kodaka, and Naomi Funaki, and Yukishige Yanagawa, and Kimiko Ubukata
December 2009, European journal of pediatrics,
Takeshi Tajima, and Eiichi Nakayama, and Yasuo Kondo, and Fumie Hirai, and Hiroaki Ito, and Taketoshi Iitsuka, and Mei Momomura, and Hirokazu Kutsuma, and Yuri Kodaka, and Naomi Funaki, and Yukishige Yanagawa, and Kimiko Ubukata
November 2012, The Pediatric infectious disease journal,
Takeshi Tajima, and Eiichi Nakayama, and Yasuo Kondo, and Fumie Hirai, and Hiroaki Ito, and Taketoshi Iitsuka, and Mei Momomura, and Hirokazu Kutsuma, and Yuri Kodaka, and Naomi Funaki, and Yukishige Yanagawa, and Kimiko Ubukata
June 2018, The Journal of infectious diseases,
Takeshi Tajima, and Eiichi Nakayama, and Yasuo Kondo, and Fumie Hirai, and Hiroaki Ito, and Taketoshi Iitsuka, and Mei Momomura, and Hirokazu Kutsuma, and Yuri Kodaka, and Naomi Funaki, and Yukishige Yanagawa, and Kimiko Ubukata
April 2004, Pediatrics,
Takeshi Tajima, and Eiichi Nakayama, and Yasuo Kondo, and Fumie Hirai, and Hiroaki Ito, and Taketoshi Iitsuka, and Mei Momomura, and Hirokazu Kutsuma, and Yuri Kodaka, and Naomi Funaki, and Yukishige Yanagawa, and Kimiko Ubukata
February 2007, Saudi medical journal,
Takeshi Tajima, and Eiichi Nakayama, and Yasuo Kondo, and Fumie Hirai, and Hiroaki Ito, and Taketoshi Iitsuka, and Mei Momomura, and Hirokazu Kutsuma, and Yuri Kodaka, and Naomi Funaki, and Yukishige Yanagawa, and Kimiko Ubukata
June 2006, Saudi medical journal,
Takeshi Tajima, and Eiichi Nakayama, and Yasuo Kondo, and Fumie Hirai, and Hiroaki Ito, and Taketoshi Iitsuka, and Mei Momomura, and Hirokazu Kutsuma, and Yuri Kodaka, and Naomi Funaki, and Yukishige Yanagawa, and Kimiko Ubukata
January 2014, Developmental period medicine,
Takeshi Tajima, and Eiichi Nakayama, and Yasuo Kondo, and Fumie Hirai, and Hiroaki Ito, and Taketoshi Iitsuka, and Mei Momomura, and Hirokazu Kutsuma, and Yuri Kodaka, and Naomi Funaki, and Yukishige Yanagawa, and Kimiko Ubukata
March 2002, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
Copied contents to your clipboard!